The 15th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, AD/PD™ 2021, was held virtually, on March 9-14, 2021.

The conference attracted international medical and scientific professionals worldwide, who discussed mechanisms of disease, prevention and treatment of Alzheimer’s disease, Parkinson’s disease and other related neurodegenerative diseases.

Explore the latest updates in the field by viewing our interviews with key experts!

View all videos

AD/PD™ 2021 Conference

Virtual Meeting, 9-14 March 2021

AD/PD™ 2021 Conference

Virtual Meeting, 9-14 March 2021

The 15th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, AD/PD™ 2021, was held virtually, on March 9-14, 2021.

The conference attracted international medical and scientific professionals worldwide, who discussed mechanisms of disease, prevention and treatment of Alzheimer’s disease, Parkinson’s disease and other related neurodegenerative diseases.

Explore the latest updates in the field by viewing our interviews with key experts!

View all videos

Latest videos from AD/PD 2021

View all
2:16
Donanemab in early-stage AD: a highlight from AD/PD
Sangram Sisodia • 16 Mar 2021
3:53
AD/PD 2021 highlights: immunotherapies, 3D cell models and copathologies
Tiago Outeiro • 16 Mar 2021
2:07
Improving Phase II trials in AD drug development
Jeffrey Cummings • 15 Mar 2021
1:24
PASADENA trial: prasinezumab in early Parkinson’s disease
Gennaro Pagano • 10 Mar 2021

Alzheimer's disease

View all
2:25
Better diagnostic methods and therapies for Alzheimer’s disease
Colin L. Masters • 11 Mar 2021
2:26
MCLENA-1: lenalidomide in mild cognitive impairment due to Alzheimer’s disease
Marwan Sabbagh • 8 Mar 2021
1:34
The influence of TREM2 variant expression in AD pathogenesis
Christina Toomey • 10 Mar 2021
4:11
Hormonal, neuroimmune, and systemic vascular influences in Alzheimer’s disease
Costantino Iadecola • 11 Mar 2021

Parkinson's disease

View all
2:40
Chronic gut inflammation confers a sex-dependent PD vulnerability
Malú Tansey • 8 Mar 2021
2:07
Opportunities for precision medicine in Parkinson’s disease: DJ-1 mutations
Rejko Krüger • 9 Mar 2021
3:34
Late-onset depression as a risk factor for prodromal PD
Anette Schrag • 15 Mar 2021
1:29
Prasinezumab: an anti-alpha-synuclein antibody in Parkinson’s disease
Gennaro Pagano • 10 Mar 2021
The content of VJNeurology is intended for healthcare professionals